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Abstract
With approximately 131 million new genital tract infections occurring each year, Chlamydia is the
most common sexually transmitted bacterial pathogen worldwide. Male and female infections
occur at similar rates and both cause serious pathological sequelae. Despite this, the impact of
chlamydial infection on male fertility has long been debated, and the effects of paternal chlamydial
infection on offspring development are unknown. Using a male mouse chronic infection model, we
show that chlamydial infection persists in the testes, adversely affecting the testicular environment.
Infection increased leukocyte infiltration, disrupted the blood:testis barrier and reduced spermio-
genic cell numbers and seminiferous tubule volume. Sperm from infected mice had decreased
motility, increased abnormal morphology, decreased zona-binding capacity, and increased DNA
damage. Serum anti-sperm antibodies were also increased. When both acutely and chronically
infected male mice were bred with healthy female mice, 16.7% of pups displayed developmental
abnormalities. Female offspring of chronically infected sires had smaller reproductive tracts
than offspring of noninfected sires. The male pups of infected sires displayed delayed testicular
development, with abnormalities in sperm vitality, motility, and sperm-oocyte binding evident at
sexual maturity. These data suggest that chronic testicular Chlamydia infection can contribute to
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Summary sentence
Testicular C. muridarum infection results in tissue damage and poor sperm quality and gives rise
to offspring with serious abnormalities and developmental delays.
Key words: Chlamydia, STI, male infertility, sperm DNA damage, offspring development.
Introduction
Chlamydia trachomatis is becoming more widely recognized as a
pathogen of the male reproductive tract (MRT) and contributing
to male infertility. With approximately 131 million new infections
occurring worldwide each year, the potential impact of such a com-
mon sexually transmitted infection on the reproductive potential of
the population is significant [1]. Many bacterial and viral infections
have been found in semen and tissues of the MRT in association
with male infertility, including C. trachomatis [2–4]. Despite male
infertility accounting for 40–50% of all infertility diagnoses [5],
the pathophysiology of MRT infections in causing infertility are
not well characterized, other than association with sperm param-
eter changes [6–8]. Hypotheses for causative mechanisms include
direct interactions between the infectious agent and spermatozoa,
impairment of MRT tissue health and functionality, and disruption
of embryogenesis [8, 9].
Testicular tissue and sperm health are important factors in clin-
ical determination of male fertility [8, 10]. A healthy testis, as
the site of sperm production (spermatogenesis), is vital to male
reproduction. There are several key cell types involved in spermato-
genesis in the testes; Sertoli cells (immune suppressive cells that
form the blood:testis barrier and provide nutritional support for
spermatogenesis), Leydig cells (interstitial androgen producing cells),
spermatogenic stem cells (progenitor cells from which all sperm
arise), peritubular myoid cells (basement membrane forming cells),
and testicular macrophages (potently immunosuppressive cells). The
blood:testis barrier and immune privilege are critical for fertility,
as breakdown can result in the generation of autoimmune T and
B lymphocytes, and production of anti-sperm antibodies [11]. This
leads to autoimmune-mediated testicular damage, germ cell loss, and
impaired sperm function [9, 11].
Some infertility or subfertility etiologies can result in dysfunc-
tional spermatogenesis with reduced sperm count (hypospermatoge-
nesis), rather than azoospermia, which is the absence of sperm [12].
These can result in seminal abnormalities that include low sperm
count (oligozoospermia), abnormal morphology (teratozoospermia),
and reduced motility (asthenozoospermia) [13]. However, combina-
tions of such defects in the same sample are common in male factor
infertility [14, 15]. In addition, sperm DNA fragmentation, which
is frequently associated with oligoasthenozoospermia, and directly
linked with embryogenesis failure and adverse pregnancy outcomes,
can occur [14, 16].
The downstream consequence of poor spermatozoa quality is a
difficulty or failure of conception. However, the impact of paternal
health, including infection, on embryo and offspring health is an
emerging field. While models of the impacts of paternal infection
on offspring health are limited, they include H. pylori transmission
between parents and children [17], and potential links between
paternal HIV [18] and hepatitis B virus [19] infection and poor off-
spring health. To date, only one rat model of Chlamydia muridarum
(a murine-specific pathogen) infection of males has been used to
investigate links between infection, fecundity, and embryonic loss
and found no adverse effects [20]. Conversely, models of maternal
infection-induced effects on fertility include a multitude of viral
[21–30], parasitic [31–34], and bacterial [35–39] pathogens. Many
of these included longitudinal and mechanistic studies, which are
completely lacking in the paternal field.
We have previously shown using a mouse model that C. muri-
darum colonizes the testes for up to 10 weeks post intra-penile infec-
tion [40, 41]. This study demonstrated that the viability of Sertoli
and spermatogenic stem cells is compromised during acute infection.
The downstream effects included decreased sperm count and motility
and increased morphologically abnormal sperm [40]. This correlates
with several studies of acute chlamydial infection of human semen,
with findings of oligospermia [7, 42, 43], teratozoospermia [7, 44],
and asthenozoospermia [7, 44]. While Chlamydia infections have
been detected in human semen [45], baboon urethra [46], koala
urethra, prostate, epididymis and testis [47] and mouse urethra,
bladder, and prostate [48], the effects of a long-term (chronic)
infection on sperm quality in both animal models and humans are
unknown and the effects on offspring are undetermined.
This study aimed to determine whether a chronic testicular C.
muridarum infection could be established in a mouse model and to
establish whether infection affects testicular cells, spermatogenesis,
fecundity, and offspring development.
Materials and methods
Ethics statement
All mice were housed under PC2 conditions and provided food
and water ad libitum, in accordance with the Australian National
Health and Medical Research Council code of practice for the care
and use of animals for scientific purposes. These experiments were
approved by Queensland University of Technology Animal Ethics
Committee (1400000250) and the University of Newcastle Animal
Ethics Committee (A-2014-412).
Mice
Mice were purchased as 6 week old C57BL/6 male mice and 12 week
old C57BL/6 female mice which had previously birthed one litter
(fertility validation), from the Animal Resource Centre (Canning
Vale, WA, AUS).
In vivo Chlamydia infection
Male mice were anaesthetized with 10 mg/kg xylazine (Bayer, NSW,
AUS) and 100 mg/kg ketamine (Parnell Laboratory, NSW, AUS)
and then infected with 1 × 106 inclusion forming units (IFU) of
C. muridarum (Weiss strain, generously gifted by Dr. Catherine
O’Connell, University of North Carolina). Mice were infected via
the intra-penile route, as described previously [41, 49].
Sperm analysis
Sperm was collected from male mice 6 months post intra-penile
infection by dissecting out the vas deferens and gently pushing out
the compacted sperm along the tubes with closed sterile forceps
into Biggers, Whitten, and Whittingham (BWW) media [50] at 290–
310 mOsm (Fisk 210 Osmometer, John Morris Group, Australia).
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CO2. Immediately following swim-up, 1 × 106 sperm was moved to
capacitating BWW media and incubated for 20 min, 37 ◦C, 5% CO2.
Capacitated sperm was assessed in a hemocytometer to quantify
the number of progressively motile sperm per milliliter. Capacitated
sperm was also incubated in droplets of BWW with C57BL/6 mouse
oocytes, collected as previously described [51], for 10 min. The
sperm-oocyte aggregates were washed to dislodge unbound sperm,
and then the remainder was viewed using light microscopy to
quantify the number of bound sperm for the zona pellucida binding
assay [52].
Capacitated and noncapacitated sperm was heat and methanol
fixed onto glass microscope slides for staining purposes. Slides were
stained with eosin Y and methylene blue to assess morphology.
Separate slides were blocked (3% BSA v/v in PBS, 1 h at room
temperature), stained with mouse anti-phosphotyrosine IgG (1:100,
ab10321, Abcam, VIC, AUS), washed twice in PBS, stained with
secondary anti-mouse IgG-Alexa Fluor(AF)488 (1:1000, A11059,
Life Technologies, VIC), washed twice in PBS, and imaged using
epifluorescence microscopy (Zeiss Axio Vert.A1, Göttingen, DE) to
quantify capacitation as described by Asquith et al. [53].
Sperm was also set into low-melting point agarose on sperm
chromatin dispersion assay (SCDA) slides at 4 ◦C for 5 min, and
then slides were placed in lysis buffer for 5 min, washed in RO
water for 5 min, fixed in 80% v/v ethanol for 2 min and 100% v/v
ethanol for 2 min as per the manufacturer’s instructions (Halotech,
Spain), and then stained with SYBR Safe DNA Gel Stain (S33102,
Invitrogen, AUS) mixed with VECTASHIELD mounting medium
(Vector Laboratories, CA) (1:1 v/v). Stained sperm was assessed for
DNA fragmentation using epifluorescence microscopy [54].
Chlamydial culture
C. muridarum for mouse infection was grown and purified by
established protocol [55]. C. muridarum was cultured from mouse
testes 6 months post-infection by homogenizing whole testes for 30 s
using a tissue homogenizer with a blade attachment (TH220, DMNI
International, Kennesaw, GA) into 500 μL of sucrose phosphate
glutamine (SPG, 74.6 g/L sucrose, 0.512 g/L KH2PO4, 1.237 g/L
K2HPO4, 5 mM L-glutamine) and quantified by infection of McCoy
cell monolayers (ATCC Cat: CRL-1696) grown in complete RPMI
1640 (10% heat-inactivated fetal calf serum, 2 μg/mL gentamycin,
and 100 μg/mL streptomycin sulfate, 1× Glutamax) at 37 ◦C, 5%
CO2, for 24 h. Monolayers were fixed with 100% methanol, washed
twice with PBS and blocked for 1 h with 5% heat-inactivated fetal
calf serum in PBS. Monolayers were incubated with primary sheep
anti-MOMP sera (1:500 v/v, [56]) diluted in blocking solution for 1
h, washed twice with PBST, and incubated for 1 h with secondary
donkey anti-sheep IgG-AF488 (2 μg/mL, Thermo Fisher Scientific,
AUS). Images were captured with epifluorescence microscopy (Zeiss
Axio Vert.A1).
Tissue histology and immunohistochemistry
Testes were harvested 6 months post-infection and placed into
either Tissue-Tek O.C.T. Compound (Pro-Sci-Tech, AUS) and frozen
at −80 ◦C or fixed in Bouin’s solution then paraffin-embedded.
Tissue blocks were sectioned (4 μm) onto hydrophilic, poly-D-lysine
coated glass microscopy slides (Thermo Fisher Scientific). O.C.T
tissues were fixed in 100% acetone, blocked in 5% v/v FCS in PBS,
and then stained. Chlamydial MOMP staining was performed as
described above. Chlamydial TC0500 staining was performed using
the same method, with primary sheep anti-TC0500 IgG (Recombi-
nant TC0500 antigen produced in house) and secondary donkey
anti-sheep-IgG-AF488 (Life Technologies). Alternatively, sections
were hematoxylin and eosin stained for tubule number analysis.
Bouin’s fixed tissues underwent antigen retrieval (all in Tris buffer
pH 10, except ZO-1: sodium citrate buffer pH 6), blocking (3%
BSA and 10% goat serum in TBS-0.1% tween), and staining for
Claudin 11 (1:100, Thermo Fisher Scientific; 1:200 goat anti-rabbit
IgG AF-555, Thermo Fisher Scientific), Zona Occludin 1 (1:100,
Abcam; 1:200 goat anti-rabbit IgG-AF555, Thermo Fisher Scien-
tific), Connexin 43 (1:50 Abcam; 1:200 goat anti-rabbit IgG-AF555,
Thermo Fisher Scientific), Connexin 37 (1:50, Alpha Diagnostics
International; goat anti-rabbit IgG-AF555, Thermo Fisher Scien-
tific), and Connexin 26 (1:50, Thermo Fisher Scientific; goat anti-
mouse IgG-AF555, Thermo Fisher Scientific). Images were captured
using epifluorescence microscopy (Zeiss Axio Vert.A1).
Anti-sperm antibodies
Whole blood was collected via cardiac bleed and then serum col-
lected post centrifugation. Enzyme linked immunosorbent assay
(ELISA) was used to determine the titer of anti-sperm antibodies in
the serum. The anti-sperm antibody (ASAB) ELISA was sourced com-
mercially from MyBioSource (MBS2603817) and was performed as
per the manufacturer’s instructions.
Mouse breeding
Infected (n = 4) and noninfected (n = 4) male mice were housed
for either 4 weeks, 8 weeks, or 5 months and then bred with two-
four noninfected C57BL/6 females each (n = 12 per group total).
Females were monitored for the presence of a vaginal plug to indicate
successful mating. Pregnant females were housed individually during
gestation (approximately 20 days) and then with newborn litters.
At 7 days post birth, the pups were tagged for later identification,
weighed, and sexed by external examination of the developing
urethra, anogenital distance, and teat marks and confirmed by an
experienced, skilled animal care technician. Pups were then weighed
every 2–3 days until the appropriate time points (euthanasia by
sodium pentobarbitone, 200 mg/kg, 47814, Virbac, NSW). The
male testes and whole female reproductive tracts of the pups were
investigated for morphology and function at 11–12, 21, and 42–
46 days post birth. The reproductive tissues were weighed post
dissection (using a dissecting microscope to remove surrounding
fatty tissue) and the organ:body weight ratio calculated.
Female pup reproductive tracts were placed into Tissue-Tek
O.C.T. Compound (Pro-Sci-Tech, AUS) and frozen at −80 ◦C. Frozen
tissue blocks were cryosectioned (4 μm) onto hydrophilic, poly-D-
lysine coated glass microscopy slides stained with hematoxylin and
eosin and then visualized with light microscopy.
The testes of male pups were placed into Tissue-Tek O.C.T.
Compound (Pro-Sci-Tech, AUS) and frozen at −80 ◦C. Frozen tissue
blocks were cryosectioned (4 μm) onto hydrophilic, poly-D-lysine
coated glass microscopy slides stained with hematoxylin and eosin
and then visualized with light microscopy. The sperm from male pups
was also isolated from the vas deferens when they reached sexual
maturity at 42–46 days post birth. Sperm was isolated and analyzed
as described previously. Additionally, the sperm count was assessed
using a hemocytometer viewed under light microscopy.
Statistical analysis
Sperm parameters and anti-sperm antibodies were analyzed using
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Figure 1. Testicular Chlamydia burden at 6 months post-infection. Six months after intra-penile infection, C. muridarum can be found in the testes by (A) culture
of live infection and (B) immunohistochemistry. Chlamydial inclusions were detected using MOMP (Bii, orange, example highlighted by white box) and active
replication marker TC0500 (Biii, aqua, example highlighted by white box), and a DAPI nuclear counterstain was also used (blue). Images were captured on 40×
objective and are representative of n = 4, and scale bars represent approximately 50 μm.
infected versus noninfected mice at single time points, unpaired,
nonparametric, Student’s t-tests were applied. In the breeding
trials, multiple comparisons two-way-ANOVAs were applied to
compare sperm parameters over multiple time points, viability of
pups was compared using a Chi-squared test (GraphPad Prism
v8), and pup weight was analyzed using a linear mixed model
accounting for “litter effects” (IBM SPSS Statistics). Histology
and immunohistochemistry (IHC) parameters were analyzed using
bootstrapped, independent samples, unpaired, Student’s t-test (SPSS).
The level of statistical significance for all tests was set at P ≤ 0.05
(∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001).
Results
C. muridarum chronically colonizes mouse testes
MRT infection in mice has previously been demonstrated to persist
for at least 3 months post-infection, long after infection has naturally
resolved in females. To determine the effects of chronic chlamydial
infection in males, mice were infected via the urethra and housed
for 6 months. The mice showed no symptoms of distress or orchitis,
in line with human data showing men had no history of overt
testicular infection or inflammation [57]. Viable C. muridarum was
detected 6 months post-infection by culture of testicular homogenate
on McCoy cells. Chlamydial growth was further validated by IHC.
Live C. muridarum was cultured from testis tissue (n = 4, Figure 1A)
at titers between 1200 and 1700 IFUs/testis, giving an average
of 1475 IFUs/testis. Immunohistochemical detection of chlamydial
major outer membrane protein (MOMP, orange, Figure 1Bii) and
early inclusion membrane protein TC0500 (CT229 homolog, green,
Figure 1Biii) also showed multiple actively replicating reticulate bod-
ies, in inclusions within testicular tissue. No C. muridarum-positive
staining was identified in any of the noninfected testes by either
culture or IHC. Taken together, these data demonstrate that viable
and replicating Chlamydia can establish a chronic infection in the
immune-privileged testes.
Chronic C. muridarum infection alters testicular
structure
To determine if chronic testicular infection affected testicular mor-
phology and function, H&E and IHC stainings were performed. His-
tological examination of H&E stained tissue showed that the luminal
area of the seminiferous tubules was significantly reduced per mm2
in infected testes compared to healthy testes (P < 0.0001, Figure 2A).
H&E stained tissue also showed significantly increased numbers of
white blood cells (WBCs) per mm2 in infected testes compared to
healthy testes (P < 0.001, Figure 2B). WBCs were identified in both
the interstitial and epithelial/luminal spaces. Immunohistochemical
detection of spermatogonial cells (marked by PCNA) showed a sig-
nificant reduction in infected compared to healthy testes (P < 0.05,
Figure 2D). Representative images of PCNA staining can be seen in
Supplementary Figure S1. Immunohistochemical detection of tight
and gap junctions within the blood:testis barrier (marked by Claudin
11 and ZO-1, and Connexin 43, respectively) showed substantial
reduction in positive signal in infected testes. Representative images
show tubules of similar stages for comparison. Similarly, Connexin
37 and 26 staining showed disruption of the basement membrane
(Supplementary Figure S1). Chronic testicular chlamydial infection
is associated with consolidation of the seminiferous tubule lumen,
enhanced immune cell infiltration, and potentially compromised
blood:testis barrier integrity.
Anti-sperm antibodies are produced by chronically
infected mice
Chronic chlamydial infection of the testes was associated with
pathological and morphological changes. To determine if breakdown
of the blood:testis barrier and leukocyte infiltration led to the devel-
opment of markers associated with male infertility, the impact of
tight-junction loss in relation to the maintenance of immune privilege
within the testis was investigated. Sperm isolated from the vas
deferens of infected mice exhibited head-head agglutination. Rep-
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Figure 2. Testicular histology at 6 months post-infection. Six months after intra-penile infection with C. muridarum, testes were harvested and stained with
haematoxylin and eosin, and specific markers. Significant differences were found in (A) area of the seminiferous tubule lumen (B) white blood cells (WBCs),
and (C) spermatogenic cells marked by proliferating cell nuclear antigen (PCNA). Staining of the blood:testis barrier (D) marked by Claudin 11, Connexin 43,
and Zona Occludin 1 (ZO-1) also showed histopathological changes (white arrows indicate presence/absence of blood:testis barrier, yellow arrows indicate
Spermatogonia). Student’s t-tests and graphs were generated with GraphPad Prism (v7), ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001, images
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Figure 3. Titres of anti-sperm antibodies present in mouse serum at 6 months. Six months post intra-penile infection with C. muridarum, anti-sperm antibodies
are significantly elevated compared to the noninfected control. Antibodies were measured by ELISA (A, MyBioSourse.com, CN, MBS2603817) and high titres
were associated with sperm agglutination in infected mice (Bii) that were not present in healthy mice (Bi). Representative images, ×20 Mag, are of sperm
isolated from the vas deferens of mice viewed by brightfield microscopy (Zeiss Axio Vert.A1, Zeiss Microscopy, DE); scale bars represent 50 μm. Student’s t-test
and graph was generated using GraphPad Prism (v7), ∗P < 0.05, n = 5.
The sperm agglutination was associated with a significant (P < 0.05)
detection of anti-sperm antibodies (ASAB) present within infected
mouse serum (average 100 ng/mL, Figure 3A). Both agglutinations
of sperm and ASAB were greatly reduced or absent in noninfected
mice (average ASAB 25 ng/mL). Enhanced ASAB production sup-
ports breakdown in immune-privilege induced by chronic chlamydial
infection.
Chronic C. muridarum infection decreases sperm
quality
To determine the downstream effects of testicular cell and tissue
changes during chronic infection, the spermatozoa produced by
these testes (retrieved from the vas deferens/cauda epididymides)
were assessed. Several sperm parameters were significantly impacted
in infected compared to noninfected mice. The forward progressive
motility was reduced from 72.7 to 48.8% (P < 0.05, Figure 4A).
Abnormal morphology (Figure 4B) (i) including (ii) head defects,
(iii) tail defects, (iv) principal piece defects, (v) head-tail connection
defects, and (vi) combinations of each type of defect increased from
12 to 26.3% (P < 0.001). Zona-pellucida binding was reduced
(Figure 4Ci–ii, P < 0.05). There were, on average, five sperm bound
per oocyte in the noninfected sperm, compared to one sperm bound
per oocyte in the infected sperm. Sperm isolated from infected mice
was significantly more likely to contain fragmented DNA (24%)
than the healthy counterparts (Figure 4Di, P < 0.01). Representative
examples of intact and fragmented sperm DNA are also shown
(Figure 4Dii–iii). Sperm with DNA fragmentation was detected in
the noninfected samples. However, the proportion remained below
∼12% and was comparable with levels of detection in healthy sperm
[6]. Lastly, sperm from infected mice also displayed premature
capacitation, measured by tyrosine phosphorylation (Figure 4E).
When isolated from noncapacitating BWW media, 71.2% of infected
group sperm was already capacitated compared to 25.1% of controls
(P < 0.05). When transferred to capacitating BWW media, infected
sperm did not undergo further capacitation (77%, P = 0.6905),
whereas an increased proportion of noninfected control sperm
did capacitate on transfer to capacitating BWW media (63.9%,
P < 0.05). Taken together, chronic chlamydial infection of the testes
is associated with attenuation of normal sperm function including
aberrant sperm motility, morphology, spontaneous capacitation,
DNA damage, and oocyte-binding.
C. muridarum infected sires produce pups with
developmental delays
As male infection was associated with morphological and functional
changes in spermatogenesis and male fertility indicators in vitro and
ex vivo, the effect of infection on fertility was evaluated in vivo.
Dams were successfully mated with either infected or noninfected
sires at three time points (1, 2 and 6 months post-infection). Dams
were not infected during this process [58]. There was no difference
in the time to conception, the rate of vaginal plug formation, or the
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Figure 4. Sperm parameters affected by testicular C. muridarum infection. Six months post intra-penile infection, sperm isolated from the vas deferens of
infected mice had significantly (A) reduced forward progressive motility, (Bi) increased amorphic sperm including (iii) minor and (iv) major head defects, (v)
incorrect tail connections, (vi) folded principal pieces, and (vii) combinations of head and tail defects, compared to normal sperm (ii), (Ci–iii) decreased oocyte
binding, and (Di–iii) elevated DNA fragmentation measured by the sperm chromatin dispersion assay (SCDA) when compared to healthy mouse sperm. The
sperm was imaged at ×20 magnification (BX41 Microscope, Olympus, USA). Scale bars represent 5 μm (B and D) or 50 μm (C). Student’s t-test was used to
analyze each parameter comparing the infected to the noninfected control samples (n = 3–7), ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001).
housed with 1-month infected males failed to conceive over a 4 week
time course. When placed with noninfected sires, they conceived
within 4 days. One dam failed in the 6-month trial failed to conceive
under either condition. Successful pregnancies progressed normally
with no difference between the group gestation times.
On the day of birth, pup viability was checked nonintrusively
so as not to cause undue stress. There were two deceased litters
found with dams from the 6-month infected group. Pup viability was
checked again 7 days post birth at the first available time that pups
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Table 1.
Day 7/21∗ Viability 1 month 2 months 6 months Total
Noninfected Infected Noninfected Infected Noninfected Infected Noninfected Infected
Viable 12 10 12 12 11 10/8 35 32/30
Nonviable 0 2 0 0 0 2/4 0 4/6
P value# 0.17 N/A 0.15/0.05 0.05/0.05
∗Day 21 pup viability when different to day 7.
#P value generated in GraphPad Prism (v8) with Chi-squared test.
two deceased litters were recorded as nonviable at day 7. In the viable
litters, there was no difference between the number and sex of pups
per litter (6 months only, Figure 5B).
At 7 days post-birth, pups were weighed for the first time. At
this time, only the 6-month group showed that sire infection caused
a significant reduction in pup weight (P < 0.05). Pups were then
weighed every 2–3 days, revealing no difference in the 1- and 2-
month groups; however, there was a consistently significantly lower
average pup weight in the 6-month infected group until day 21
(weaning, Figure 5A) compared to controls. At day 21, weaning
occurred in all groups, and viability was reassessed (Table 1). At
weaning, two litters from the 6-month infected breeding group,
in line with animal ethics requirements, were euthanized. Several
criteria determined this; each pup in the two litters was lighter by
approximately 20% than the average noninfected breeding group
pup, each pup was unable to provide food and water for themselves,
and each pup exhibited significant developmental delay compared to
the controls.
At 14 days post-birth, developmental abnormalities were evident
in pups from 6-month infected sires. In the representative photo-
graphic examples in Figure 5Ci–ii, at day 14, all noninfected group
pups opened their eyes whereas all the infected group pups’ eyes
remained closed. Similarly, at day 14, the pup crown-rump lengths
were measured, and within the 6-month infected group the pups were
shorter (Figure 5Ciii–iv). These abnormal development trends were
observed within all litters born to the 6-month infected group, not
limited to the particularly unhealthy litters.
Pups sired by C. muridarum chronically infected sires
have attenuated reproductive tract development
At day 42 post-birth, the female pup reproductive tracts (FRTs,
whole tissue between the cervix-ovary) were weighed. There
was a significant reduction (P < 0.01) in the 6-month infected
breeding group compared to the noninfected breeding group pups
(Figure 5D). When normalized to the body weight to achieve an
FRT:body weight ratio, this trend was less pronounced (P = 0.0682,
Figure 5E). The representative images show histological sections
of the FRTs, after being stained with H&E (Supplementary Figure
S3A). These images show the structure and vaginal glands, which
are a healthy functioning indicator, in both breeding groups.
The testes of the male pups were harvested at day 11, at which
time spermatogenesis and spermatogenic cell meiosis are known to
occur. There was a significant difference in the weight (Figure 5F)
and the testis:body weight ratio (Figure 5G) between the 6-month
breeding groups, where the infected group pups had significantly
smaller testes (P < 0.001) and a significantly reduced testis:body
weight ratio (P < 0.01). The differences between the groups at the
later time-points of day 21 and 42 were nonsignificant (Supplemen-
tary Figure S3B). However, these time-points were unable to include
the euthanized abnormal pups, so they represent a sub-population
of testes from mice with infected sires. Histological sections from
the testes harvested at day 21 were stained with H&E (Supple-
mentary Figure S3C) and displayed a significantly decreased num-
ber of seminiferous tubules/mm2 in the infected group (Figure 5H,
P < 0.01).
Pups sired by C. muridarum infected sires have lower
quality sperm
Sperm from the pups of sires infected for 1, 2, or 6 months prior to
mating was analyzed. The sperm from the male pups was analyzed at
day 42 as the earliest time-point when sperm can be collected from
the cauda epididymis and vas deferens. The pups of sires infected
for 6 months had reduced sperm counts compared to the pups of
healthy sires (P < 0.05, Supplementary Figure S4). Pups from 6-
month sires also had the lowest sperm vitality compared to the 1-
and 2-month groups, and the lowest overall vitality resulted from
chronic 6-month sire infection (P < 0.05) compared to healthy
counterparts (Figure 6A). Forward progressive motility (Figure 6B)
was consistently reduced in pups from infected sires, significantly so
in the 2-month group (P < 0.01).
When sperm from pups was used in oocyte-binding assays, non-
capacitated sperm was unable to bind oocytes in significant numbers
in all groups. When sperm was moved to capacitation media, positive
oocyte binding was recorded for all noninfected groups, but only the
one (P < 0.0001) and 2-month groups (P < 0.0001), not the 6-month
group (P > 0.05), for infected groups. The number of sperm bound
to oocytes in the 1- and 2-month groups was also significantly lower
in infected conditions compared to noninfected controls. There were
also significant decreases in the amount of sperm bound to oocytes as
age of sires increased, between the 1- and 2-month groups (P < 0.05),
the 1- and 6-month groups (P < 0.0001), and the 2- and 6-month
groups (P < 0.0001) under both noninfected and infected conditions.
Thus, chronic male infection can attenuate the normal development
of offspring and has an effect on male progeny sperm function.
Furthermore, spermatozoal function declines with the duration of
sire infection.
Discussion
Chlamydia can be found in the testes of mice 6 months after intra-
penile infection, and this exceeds the previous studies of mouse
chlamydial infection chronicity [40]. The health of the testicular
environment is compromised by chronic infection. Significant loss
of the key blood:testis barrier structure occurred during infection
and was associated with immune cell infiltration and anti-sperm








estern Sydney user on 23 June 2020
896 E. Bryan et al., 2020, Vol. 102, No. 4
Figure 5. Pup development parameters affected by having C. muridarum infected sires. Infected sires gave rise to pups with (A) altered weight and weight gain
(1, 2, and 6 months), (B) unaltered sex ratio, and altered (C, day 14) developmental time lines of “eye opening” and length, female reproductive tract (D, day 42)
weight and (E, day 42) weight:body weight ratio, MRT (F, day 11) weight and (G, day 11) weight:body weight ratio, and (H, day 21) testes with fewer seminiferous
tubules (6 months only). Student’s t-test was used to analyze each parameter comparing the infected to the noninfected breeding groups (n = 11–12), ∗P < 0.05
(B, corresponds to 6 months), ∗∗P < 0.01, ∗∗∗P < 0.001).
spermatogenesis, causing significantly decreased sperm quality.
Sperm morphology, motility, DNA integrity, capacitation, and
oocyte binding capability were all significantly adversely impacted
by infection, indicating a major dysregulation of spermatogenesis.
While this does not represent overt infertility, reductions correlated
with decreased offspring viability and development of abnormal
sperm in surviving offspring.
The chlamydial inclusions identified by immunohistochemistry
contain actively replicating Chlamydia, demonstrated by MOMP
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Figure 6. Pup sperm parameters affected by C. muridarum infected sires. (A) The oldest sires produced pups with the lowest sperm vitality and chronically
infected sires produced pups with the lowest overall vitality. (B) Infected group pups had low forward progressive motility. (C) Infection group sperm had
reduced oocyte binding capability. Multiple comparisons two-way-ANOVA was used to analyze each parameter comparing the infected to the noninfected
control samples (n = 10) or the noncapacitated to capacitated sperm in the binding assay over time. One- and two-month studies were completed at The
University of Newcastle, and the 6-month study at Queensland University of Technology, n = 3–10, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001.
from testicular lysates. This indicates that a low-grade but productive
chronic infection was established and continued to be identifiable
for at least 6 months. Productive infections are likely to remain
sexually transmittable, as we have previously been able to culture
viable Chlamydia from prostatic secretions [41]. It is unclear at
this time which testicular cell types are perpetuating the chronic
infection, and this requires further investigation. However, we have
previously reported that Sertoli and spermatogenic cells are suscep-
tible to infection and are apoptotic in the presence of infection and
inflammation [40].
Infiltrating WBCs may induce inflammatory conditions to pro-
mote apoptosis in testicular cells. While testicular macrophages are
normally able to maintain an anti-inflammatory environment, other
recruited macrophages or polymorphonuclear cells may override this
effect [59–61]. Alternatively, the infiltrating immune cells may be
partially responsible for maintaining the infection within the testes.
Chlamydiae are known to survive within DCs [62, 63], neutrophils
[64], monocytes [65], and macrophages [66, 67].
Immune cell infiltration and loss of immune privilege, indi-
cated by the reduced abundance of ZO-1/Claudin 11+ tight junc-
tions and Connexin26/37/43+ gap junctions, in infected testes likely
lead to production of ASABs [68]. These ASABs may be respon-
sible for the frequent agglutination of sperm heads that occurred
within infected sperm samples [69]. Several alternatives may be
possible for the cause of the ASAB production, including break-
down of the epididymal partial immune-privilege [70, 71]. The
sperm agglutination may also be Chlamydia-mediated, indepen-
dent of ASAB presence, via ligand binding [72, 73]. Regardless,
sperm agglutination could be inhibitory in the setting of natu-
ral human conception, as it would impede forward progressive
motility though an overt impact was not observed in this mouse
model.
In this study, multiple sperm parameters were altered during
infection. Interestingly, infected mice had significantly greater num-
bers of sperm with DNA fragmentation than healthy mice. Sperm
DNA integrity is important for fertility [74]. Mature sperm does
not have DNA repair capability [75], instead the oocyte carries out
DNA repair after fertilization [75]. However, in some cases, the
excessive damage requiring repair causes a delay in the time for
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embryogenic failure and adverse pregnancy outcomes, for example,
miscarriage [75, 76].
Asthenozoospermia is also associated with DNA fragmentation.
This is hypothesized to be the result of metabolic deregulation as a
downstream effect of functional gene fragmentation [14]. This trend
was observed here; infected mice produced significantly fewer motile
sperm. Sperm that lack forward motility will have reduced capability
to traverse the FRT and compete for binding of an oocyte.
Sperm morphology will also influence the motility and oocyte
binding capacity [77], although humans have remarkably few mor-
phologically normal sperm so conclusions drawn from this result
are limited [13]. The sperm produced by infected mice in this study
had significantly higher amounts of amorphic sperm compared to
the healthy mice. This correlates with a study that also found that
C. trachomatis infections in men resulted in higher percentage of
amorphic sperm present in semen [44].
Capacitation is also an important factor in oocyte binding,
as sperm lacking or having prematurely undergone capacitation
cannot complete an acrosome reaction and achieve fertilization
[78]. The sperm isolated from infected mice displayed premature
capacitation, marked by significantly increased levels of tyrosine
phosphorylation. The mechanism for Chlamydia-mediated induc-
tion of premature sperm capacitation in this study requires further
investigation. Some studies suggest that Chlamydia adheres to the
outside of sperm, causing molecular changes that induce capaci-
tation [79, 80]. In vitro tyrosine phosphorylation (TP) in human
spermatozoa was induced by co-incubation with C. trachomatis
[80]. TP is intrinsically involved with sperm capacitation, making
it a useful marker in establishing sperm capacitation status [81].
Alternatively, some studies show that Chlamydia spp. can alter the
redox balance within host cells as a result of ROS production [82,
83]. Redox-mediated regulation of sperm capacitation is also well
characterized [78].
Regardless of the mechanism of chlamydial infection-induced
impairment of multiple sperm parameters, the effect was reduced
oocyte binding. Only noninfected, capacitated mouse sperm were
able to bind oocytes in significant numbers. This indicates a sig-
nificant likelihood of infection-induced sub-fertility in vivo. In a
human IVF setting, this suggests that sperm from an infected indi-
vidual would be less likely to bind an oocyte. Combined with the
DNA fragmentation present in infected sperm, intra-cytoplasmic
sperm injection which bypasses oocyte binding may also be less
successful [84].
To study the functional outcomes of the sperm abnormalities,
sires were infected for 1, 2, or 6 months and then mated with
noninfected, healthy dams. The offspring born to chronically 6-
month infected sires rather than the 1- and 2-month infected sires
displayed low birth weight, developmental delays, and abnormalities
of reproductive tract development. Female offspring had smaller,
though histologically normal appearing, reproductive tracts, while
males had smaller testes.
A commonality between the 1-, 2- and 6-month infected groups
was that male pups had poor sperm quality (reduced sperm count,
motility, and capacitation/oocyte binding ability). Low sperm quality
may be due to testicular abnormalities, as the number of seminiferous
tubules in the testes of pups from 6 month infected sires was signif-
icantly reduced. The sperm quality declined in direct correlation to
the length of paternal infection, i.e., 6-month infected sires gave rise
to the pups with the worst sperm quality.
There was no difference in conception rate between the infected
and noninfected breeding groups (at any time point). In mice, acute
depression of sperm function would be required to cause infertility,
which was not the case here. Sufficient functional sperm is still
present, and this sperm will generate normal conception rates and
numbers of offspring. This hypothesis accounts for the proportion
of pups from the infected breeding groups with normal weight
and reproductive tract development. However, of more immediate
biological importance were the nonviable litters produced at two
time points.
Sperm with single or nondeleterious abnormalities may also be
present, for example, varying amounts of DNA fragmentation. The
variability could explain the presence of both viable and nonviable
litters within the infected group. Unfortunately, whether nonviable
litters were stillborn or if they died after birth could not be deter-
mined. Dams have altered maternal behavior, including cannibalizing
neonates if stillborn, particularly unhealthy, or in stressful environ-
ments [85, 86]. Multiple other healthy litters were born to both
groups on the same day as the nonviable litters, suggesting that pups
were stillborn or unhealthy. Two out of twelve chronic 6-month
infected breeding group litters also had very low birth-weights; they
were not cannibalized by the dams but were euthanized before
weaning. Four nonviable chronic infection group litters combined
with two failure-to-conceive litters from the acute infection groups
resulted in six out of thirty-five nonviable pregnancies.
The abnormalities present in at least two of the chronically
infected breeding group litters could have been the product of
several factors. Firstly, improper repair and/or replication of frag-
mented DNA present within sire sperm may contribute to offspring
abnormalities, as previously discussed [87, 88]. Sperm DNA frag-
mentation, although strongly correlated with adverse pregnancy
outcomes, can also lead to fetal malformation [76]. This has been
studied extensively in humans with sperm apoptosis and ROS as
the etiological agents [89]. This is usually in the context of paternal
transmission of genetic mutations/diseases including Y chromosome
deletion, achondroplasia, and the predisposition of childhood cancer
development [89]. Genetic diseases such as achondroplasia found in
offspring of older males are particularly relevant to the two abnormal
litters produced from breeding infected sires as these litters showed
delayed development initially and then by weaning, development was
significantly stunted [90]. This resulted in the litters containing small
pups around half the size of the average healthy pup.
An additional factor that may contribute to the abnormal litters
is epigenetic changes (epimutation) within the germ line and the
sperm itself. It is now accepted that epimutation including to micro
and noncoding RNA within the germline is potentially carried
within gametes leading to epigenetic inheritance [91–94] and that
Chlamydia can induce methylation mutation on such sites [95–97].
From a reproduction-specific viewpoint, there is some evidence that
men conceived via IVF due to male factor infertility had infertility
problems of their own later in life [98, 99] and in murine models of
maternal cigarette smoking and paternal DDT exposure that male
infertility can be transgenerational up to F3 generations [52, 100].
The effects of Chlamydia infection may be due to epimutation and as
such the current intergeneration effect may also be transgenerational;
however, this is hypothetical as no mechanism has been yet been
identified. A combination of DNA fragmentation and epimutation
in the male germ line could be a key determinant in the role of
Chlamydia in offspring mortality and morbidity.
Given the frequency of the diagnosed Chlamydia infections in
the human population, these results indicate that there is cause for
concern past those immediate issues normally associated with infec-
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there is an alarming potential for chlamydial infections to impact
the fertility of a large portion of the human male population, either
directly, through decreasing the quality of the father’s sperm, or
indirectly, through decreasing the quality of the offspring’s sperm.
Supplementary data
Supplementary data is available at BIOLRE online.
Acknowledgments
The work was supported by the National Health and Medical Research
Council (APP1062198). AJC was supported by an NHMRC ECR Fellowship
(APP1052464). We also acknowledge the support of the Ian Potter Foundation
for the Zeiss microscope and thank Prof. Jaime Gosalvez (Free University
of Madrid) for the Sperm Chromatin Dispersion Assay, and Donna West at
the QUT-MERF animal house facility and Ryan Perry at the University of
Newcastle for assistance with the breeding component of the study.
Conflict of interest
The authors have declared that no conflict of interest exists.
References
1. WHO. Sexually transmitted infections (STIs). Fact Sheets: World Health
Organization; 2019.
2. Pellati D, Mylonakis I, Bertoloni G, Fiore C, Andrisani A, Ambrosini G,
Armanini D. Genital tract infections and infertility. Eur J Obstet Gynecol
Reprod Biol 2008; 140:3–11.
3. Dejucq N, Jégou B. Viruses in the mammalian male genital tract and their
effects on the reproductive system. Microbiol Mol Biol Rev 2001; 65:
208–231.
4. Govero J, Esakky P, Scheaffer SM, Fernandez E, Drury A, Platt DJ,
Gorman MJ, Richner JM, Caine EA, Salazar V. Zika virus infection
damages the testes in mice. Nature 2016; 540:438–442.
5. Kumar N, Singh AK. Trends of male factor infertility, an important cause
of infertility: A review of literature. Journal of Human Reproductive
Sciences 2015; 8:191–196.
6. Gallegos G, Ramos B, Santiso R, Goyanes V, Gosálvez J, Fernández JL.
Sperm DNA fragmentation in infertile men with genitourinary infec-
tion by chlamydia trachomatis and mycoplasma. Fertil Steril 2008; 90:
328–334.
7. Gdoura R, Keskes-Ammar L, Bouzid F, Eb F, Hammami A, Orfila J.
Chlamydia trachomatis and male infertility in Tunisia. Eur J Contracept
Reprod Health Care 2001; 6:102–107.
8. Moazenchi M, Totonchi M, Salman Yazdi R, Hratian K, Mohseni Mey-
bodi MA, Ahmadi Panah M, Chehrazi M, Mohseni MA. The impact of
chlamydia trachomatis infection on sperm parameters and male fertility:
A comprehensive study. Int J STD AIDS 2017; 956462417735245.
9. Redgrove KA, McLaughlin EA. The role of the immune response in
chlamydia trachomatis infection of the male genital tract: A double-
edged sword. Front Immunol 2014; 5:534.
10. Dohle GR, Elzanaty S, van Casteren NJ. Testicular biopsy: Clinical
practice and interpretation. Asian J Androl 2012; 14:88–93.
11. Fijak M, Iosub R, Schneider E, Linder M, Respondek K, Klug J,
Meinhardt A. Identification of immunodominant autoantigens in rat
autoimmune orchitis. J Pathol 2005; 207:127–138.
12. Cheng YS, Lu CW, Lin TY, Lin PY, Lin YM. Causes and clinical features
of infertile men with nonobstructive Azoospermia and Histopathologic
diagnosis of Hypospermatogenesis. Urology 2017; 105:62–68.
13. WHO. WHO laboratory manual for the examination and processing of
human semen. In, vol. Fifth Edition. ISBN 978 92 4 154778 9: World
Health Organization; 2010.
14. Belloc S, Benkhalifa M, Cohen-Bacrie M, Dalleac A, Chahine H, Amar
E, Zini A. Which isolated sperm abnormality is most related to sperm
DNA damage in men presenting for infertility evaluation. J Assist Reprod
Genet 2014; 31:527–532.
15. Oehninger S. Pathophysiology of oligoasthenoteratozoospermia: Are we
improving in the diagnosis? Reprod Biomed Online 2003; 7:433–439.
16. Larson-Cook KL, Brannian JD, Hansen KA, Kasperson KM, Aamold ET,
Evenson DP. Relationship between the outcomes of assisted reproductive
techniques and sperm DNA fragmentation as measured by the sperm
chromatin structure assay. Fertil Steril 2003; 80:895–902.
17. Rothenbacher D, Winkler M, Gonser T, Adler G, Brenner H. Role of
infected parents in transmission of helicobacter pylori to their children.
Pediatr Infect Dis J 2002; 21:674–679.
18. Semprini AE, Ravizza M, Muggiasca ML, Giuntelli S, Fiore S, Pardi G.
Paternal HIV infection and transfer of HIV from mother to fetus. BMJ
1994; 308:453.
19. Oster E, Chen G, Yu X, Lin W. Hepatitis B does not explain male-biased
sex ratios in China. Economics Letters 2010; 107:142–144.
20. Motrich RD, Sanchez L, Maccioni M, Mackern-Oberti JP, Rivero VE.
Male rat genital tract infection with chlamydia muridarum has no
significant consequence on male fertility. J Urol 2012; 187:1911–1917.
21. Brocklehurst P, French R. The association between maternal HIV infec-
tion and perinatal outcome: A systematic review of the literature and
meta-analysis. BJOG 1998; 105:836–848.
22. Corey L, Wald A. Maternal and neonatal herpes simplex virus infections.
N Engl J Med 2009; 361:1376–1385.
23. Dahlquist G, Frisk G, Ivarsson S, Svanberg L, Forsgren M, Diderholm H.
Indications that maternal coxsackie B virus infection during pregnancy
is a risk factor for childhood-onset IDDM. Diabetologia 1995; 38:
1371–1373.
24. Elfving M, Svensson J, Oikarinen S, Jonsson B, Olofsson P, Sundkvist G,
Lindberg B, Lernmark Å, Hyöty H, Ivarsson S-A. Maternal enterovirus
infection during pregnancy as a risk factor in offspring diagnosed with
type 1 diabetes between 15 and 30 years of age. Exp Diabetes Res 2008;
2008.
25. Freij B, South M, Sever J. Maternal rubella and the congenital rubella
syndrome. Clin Perinatol 1988; 15:247–257.
26. Lao TT, Chan BC, Leung W-C, Ho L-F, Tse K-Y. Maternal hepatitis B
infection and gestational diabetes mellitus. J Hepatol 2007; 47:46–50.
27. Monif GR. Maternal mumps infection during gestation: Observations
on the progeny. Am J Obstet Gynecol 1974; 119:549–551.
28. Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S. Congenital
cytomegalovirus infection following first trimester maternal infection:
Symptoms at birth and outcome. J Clin Virol 2006; 35:216–220.
29. Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and Fetal out-
comes in pregnant women with acute hepatitis E virus InfectionMaternal
and Fetal outcomes in HEV-infected pregnant women. Ann Intern Med
2007; 147:28–33.
30. Short SJ, Lubach GR, Karasin AI, Olsen CW, Styner M, Knickmeyer
RC, Gilmore JH, Coe CL. Maternal influenza infection during pregnancy
impacts postnatal brain development in the rhesus monkey. Biol Psychi-
atry 2010; 67:965–973.
31. Brown AS, Schaefer CA, Quesenberry CP Jr, Liu L, Babulas VP, Susser
ES. Maternal exposure to toxoplasmosis and risk of schizophrenia in
adult offspring. Am J Psychiatry 2005; 162:767–773.
32. Le Hesran JY, Cot M, Personne P, Fievet N, Dubois B, Beyeme M, Boudin
C, Deloron P. Maternal placental infection with plasmodium falciparum
and malaria morbidity during the first 2 years of life. Am J Epidemiol
1997; 146:826–831.
33. Torrico F, Alonso-Vega C, Suarez E, Rodriguez P, Torrico M-C, Dra-
maix M, Truyens C, Carlier Y. Maternal Trypanosoma cruzi infection,
pregnancy outcome, morbidity, and mortality of congenitally infected
and non-infected newborns in Bolivia. Am J Trop Med Hyg 2004; 70:
201–209.
34. Vekemans J, Truyens C, Torrico F, Solano M, Torrico M-C, Rodriguez








estern Sydney user on 23 June 2020
900 E. Bryan et al., 2020, Vol. 102, No. 4
upregulates capacity of uninfected neonate cells to produce pro-and anti-
inflammatory cytokines. Infect Immun 2000; 68:5430–5434.
35. Elliott B, Brunham RC, Laga M, Piot P, Ndinya-Achola JO, Maitha G,
Cheang M, Plummer FA. Maternal gonococcal infection as a preventable
risk factor for low birth weight. J Infect Dis 1990; 161:531–536.
36. Grigsby PL, Novy MJ, Sadowsky DW, Morgan TK, Long M, Acosta E,
Duffy LB, Waites KB. Maternal azithromycin therapy for Ureaplasma
intraamniotic infection delays preterm delivery and reduces fetal lung
injury in a primate model. Am J Obstet Gynecol 2012; 207:475 e471-
475. e414.
37. Watson-Jones D, Changalucha J, Gumodoka B, Weiss H, Rusizoka
M, Ndeki L, Whitehouse A, Balira R, Todd J, Ngeleja D. Syphilis in
pregnancy in Tanzania. I. Impact of maternal syphilis on outcome of
pregnancy. J Infect Dis 2002; 186:940–947.
38. Pang Y, Rodts-Palenik S, Cai Z, Bennett WA, Rhodes PG. Suppression
of glial activation is involved in the protection of IL-10 on maternal E.
coli induced neonatal white matter injury. Developmental brain research
2005; 157:141–149.
39. Smith B, Kemp M, Ethelberg S, Schiellerup P, Bruun BG, Gerner-Smidt
P, Christensen JJ. Listeria monocytogenes: Maternal-foetal infections in
Denmark 1994–2005. Scand J Infect Dis 2009; 41:21–25.
40. Sobinoff AP, Dando SJ, Redgrove KA, Sutherland JM, Stanger SJ,
Armitage CW, Timms P, McLaughlin EA, Beagley KW. Chlamydia
muridarum infection-induced destruction of male germ cells and Ser-
toli cells is partially prevented by chlamydia major outer membrane
protein-specific immune CD4 cells 1. Biol Reprod 2014; 92:Article 27:
21–13.
41. O’Meara CP, Armitage CW, Kollipara A, Andrew DW, Trim L, Plen-
derleith MB, Beagley KW. Induction of partial immunity in both males
and females is sufficient to protect females against sexual transmission
of chlamydia. Mucosal Immunol 2016; 9:1076–1088.
42. Joki-Korpela P, Sahrakorpi N, Halttunen M, Surcel H-M, Paavonen J,
Tiitinen A. The role of chlamydia trachomatis infection in male infertility.
Fertil Steril 2009; 91:1448–1450.
43. Hosseinzadeh S, Brewis I, Eley A, Pacey A. Co-incubation of human
spermatozoa with chlamydia trachomatis serovar E causes premature
sperm death. Hum Reprod 2001; 16:293–299.
44. Veznik Z, Pospisil L, Svecova D, Zajicova A, Unzeitig V. Chlamydiae in
the ejaculate: Their influence on the quality and morphology of sperm.
Acta Obstet Gynecol Scand 2004; 83:656–660.
45. van den Brule AJC, Hemrika DJ, Walboomers JMM, Raaphorst P, van
Amstel N, Bleker OP, Meijer CJLM. Detection of chlamydia trachomatis
in semen of artificial insemination donors by the polymerase chain
reaction. Fertil Steril 1993; 59:1098–1104.
46. Digiacomo RF, Gale JL, Wang SP, Kiviat MD. Chlamydial infection of
the male baboon urethra. Br J Vener Dis 1975; 51:310–313.
47. Palmieri C, Hulse L, Pagliarani S, Larkin R, Higgins DP, Beagley K,
Johnston S. Chlamydia pecorum infection in the male reproductive
system of koalas (Phascolarctos cinereus). Vet Pathol 2019; 56:300–306.
48. Sanchez LR, Breser ML, Godoy GJ, Salazar FC, Mackern-Oberti JP,
Cuffini C, Motrich RD, Rivero VE. Chronic infection of the prostate by
chlamydia muridarum is accompanied by local inflammation and pelvic
pain development. Prostate 2017; 77:517–529.
49. Pal S, Peterson EM, de la Maza LM. New murine model for the study
of chlamydia trachomatis genitourinary tract infections in males. Infect
Immun 2004; 72:4210–4216.
50. Biggers JD, Whittemn WK, Whittingham DG. The culture of mouse
embryos in vitro. In: Daniel JC (ed.), Methods in mammalian embry-
ology. San Francisco: W.H. Freeman & Co; 1971: 86–116.
51. Mihalas BP, Western PS, Loveland KL, McLaughlin EA, Holt JE.
Changing expression and subcellular distribution of karyopherins during
murine oogenesis. Reproduction 2015; 150:485–496.
52. Sobinoff AP, Sutherland JM, Beckett EL, Stanger SJ, Johnson R, Jarnicki
AG, McCluskey A, St John JC, Hansbro PM, McLaughlin EA. Damaging
legacy: Maternal cigarette smoking has long-term consequences for male
offspring fertility. Hum Reprod 2014; 29:2719–2735.
53. Asquith KL, Baleato RM, McLaughlin EA, Nixon B, Aitken RJ. Tyrosine
phosphorylation activates surface chaperones facilitating sperm-zona
recognition. J Cell Sci 2004; 117:3645–3657.
54. Fernandez JL, Vazquez-Gundin F, Delgado A, Goyanes VJ, Ramiro-Diaz
J, de la Torre J, Gosalvez J. DNA breakage detection-FISH (DBD-FISH)
in human spermatozoa: Technical variants evidence different structural
features. Mutat Res 2000; 453:77–82.
55. Howard L, Orenstein NS, King NW. Purification on renografin density
gradients of chlamydia trachomatis grown in the yolk sac of eggs. Appl
Microbiol 1974; 27:102–106.
56. O’Meara CP, Armitage CW, Harvie MC, Timms P, Lycke NY, Beagley
KW. Immunization with a MOMP-based vaccine protects mice against a
pulmonary chlamydia challenge and identifies a disconnection between
infection and pathology. PLoS One 2013; 8:e61962.
57. Bryan ER, McLachlan RI, Rombauts L, Katz DJ, Yazdani A, Bogoevski
K, Chang C, Giles ML, Carey AJ, Armitage CW, Trim LK, McLaughlin
et al. Detection of chlamydia infection within human testicular biopsies.
Hum Reprod 2019; 34:p1891–p1898.
58. O’Meara C, Andrew D, Beagley K. The mouse model of chlamydia
genital tract infection: A review of infection, disease, immunity and
vaccine development. Curr Mol Med 2014; 14:396–421.
59. Guazzone VA, Rival C, Denduchis B, Lustig L. Monocyte chemoat-
tractant protein-1 (MCP-1/CCL2) in experimental autoimmune orchitis.
J Reprod Immunol 2003; 60:143–157.
60. Tung K, Yule TD, Mahi-Brown CA, Listrom MB. Distribution of
histopathology and Ia positive cells in actively induced and passively
transferred experimental autoimmune orchitis. J Immunol 1987; 138:
752–759.
61. Yule TD, Tung KS. Experimental autoimmune orchitis induced by testis
and sperm antigen-specific T cell clones: An important pathogenic
cytokine is tumor necrosis factor. Endocrinology 1993; 133:1098–1107.
62. Armitage CW, O’Meara CP, Beagley KW. Chlamydia pneumoniae and
chlamydia trachomatis infection differentially modulates human den-
dritic cell line (MUTZ) differentiation and activation. Scand J Immunol
2015; 82:48–54.
63. Gervassi A, Alderson MR, Suchland R, Maisonneuve JF, Grabstein KH,
Probst P. Differential regulation of inflammatory cytokine secretion
by human dendritic cells upon chlamydia trachomatis infection. Infect
Immun 2004; 72:7231–7239.
64. Rupp J, Pfleiderer L, Jugert C, Moeller S, Klinger M, Dalhoff K, Solbach
W, Stenger S, Laskay T, van Zandbergen G. Chlamydia pneumoniae
hides inside apoptotic neutrophils to silently infect and propagate in
macrophages. PLoS One 2009; 4:e6020.
65. Airenne S, Surcel H-M, Alakärppä H, Laitinen K, Paavonen J, Saikku P,
Laurila A. Chlamydia pneumoniae infection in human monocytes. Infect
Immun 1999; 67:1445–1449.
66. Buchacher T, Ohradanova-Repic A, Stockinger H, Fischer MB, Weber V.
M2 polarization of human macrophages favors survival of the intracel-
lular pathogen chlamydia pneumoniae. PLoS One 2015; 10:e0143593.
67. Wittkop U, Peppmueller M, Njau F, Leibold W, Klos A, Krausse-Opatz
B, Hudson AP, Zeidler H, Haller H, Wagner AD. Transmission of
Chlamydophila pneumoniae from dendritic cells to macrophages does
not require cell-to-cell contact in vitro. J Microbiol Methods 2008;
72:288–295.
68. Kohno S, Munoz J, Williams T, Teuscher C, Bernard C, Tung K.
Immunopathology of murine experimental allergic orchitis. J Immunol
1983; 130:2675–2682.
69. Jager S, Kremer J, van Slochteren-Draaisma T. A simple method of
screening for antisperm antibodies in the human male. Detection of
spermatozoal surface IgG with the direct mixed antiglobulin reaction
carried out on untreated fresh human semen. Int J Fertil 1978; 23:12–21.
70. Mital P, Hinton BT, Dufour JM. The blood-testis and blood-epididymis
barriers are more than just their tight junctions. Biol Reprod 2011;
84:851–858.
71. Nilsson S, Nilsson B, Johannisson G, Lycke E. Acute epididymitis and








estern Sydney user on 23 June 2020
Chronic Chlamydia infection impairs male fertility, 2020, Vol. 102, No. 4 901
72. Monga M, Roberts JA. Spermagglutination by bacteria: Receptor-
specific interactions. J Androl 1994; 15:151–156.
73. Swanson AF, Ezekowitz RAB, Lee A, C-c K. Human mannose-binding
protein inhibits infection of HeLa cells by chlamydia trachomatis. Infect
Immun 1998; 66:1607–1612.
74. Bungum M, Humaidan P, Axmon A, Spano M, Bungum L, Erenpreiss J,
Giwercman A. Sperm DNA integrity assessment in prediction of assisted
reproduction technology outcome. Hum Reprod 2007; 22:174–179.
75. Sakkas D, Alvarez JG. Sperm DNA fragmentation: Mechanisms of
origin, impact on reproductive outcome, and analysis. Fertil Steril 2010;
93:1027–1036.
76. Gawecka JE, Marh J, Ortega M, Yamauchi Y, Ward MA, Ward WS.
Mouse zygotes respond to severe sperm DNA damage by delaying
paternal DNA replication and embryonic development. PLoS One 2013;
8:e56385.
77. Kaskar K, Franken DR, Van Der Horst G, Oehninger S, Kruger TF,
Hodgen GD. The relationship between morphology, motility and zona
pellucida binding potential of human spermatozoa. Andrologia 1994;
26:1–4.
78. Aitken RJ. Reactive oxygen species as mediators of sperm capacitation
and pathological damage. Mol Reprod Dev 2017; 84:1039–1052.
79. Wølner-Hanssen P, Mårdh P-A. In vitro tests of the adherence of
chlamydia trachomatis to human spermatozoa. Fertil Steril 42:102–107.
80. Hosseinzadeh S, Brewis IA, Pacey AA, Moore HDM, Eley A. Coincuba-
tion of human spermatozoa with chlamydia trachomatis in vitro causes
increased tyrosine phosphorylation of sperm proteins. Infect Immun
2000; 68:4872–4876.
81. Naz RK, Rajesh PB. Role of tyrosine phosphorylation in sperm capac-
itation/acrosome reaction. Reproductive biology and endocrinology:
RB&E 2004; 2:75–75.
82. Prusty BK, Böhme L, Bergmann B, Siegl C, Krause E, Mehlitz A, Rudel
T. Imbalanced oxidative stress causes chlamydial persistence during
non-productive human herpes virus co-infection. PLoS One 2012; 7:
e47427.
83. Abdul-Sater AA, Saïd-Sadier N, Lam VM, Singh B, Pettengill MA,
Soares F, Tattoli I, Lipinski S, Girardin SE, Rosenstiel P, Ojcius DM.
Enhancement of reactive oxygen species production and chlamydial
infection by the mitochondrial nod-like family member NLRX1. J Biol
Chem 2010; 285:41637–41645.
84. Simon L, Zini A, Dyachenko A, Ciampi A, Carrell DT. A systematic
review and meta-analysis to determine the effect of sperm DNA damage
on in vitro fertilization and intracytoplasmic sperm injection outcome.
Asian J Androl 2017; 19:80–90.
85. Weber EM, Algers B, Hultgren J, Olsson IA. Pup mortality in laboratory
mice–infanticide or not? Acta Vet Scand 2013; 55:83.
86. Meek LR, Dittel PL, Sheehan MC, Chan JY, Kjolhaug SR. Effects of
stress during pregnancy on maternal behavior in mice. Physiol Behav
2001; 72:473–479.
87. Tesarik J, Greco E, Mendoza C. Late, but not early, paternal effect on
human embryo development is related to sperm DNA fragmentation.
Hum Reprod 2004; 19:611–615.
88. Fernández-Gonzalez R, Moreira PN, Pérez-Crespo M, Sánchez-Martín
M, Ramirez MA, Pericuesta E, Bilbao A, Bermejo-Alvarez P, Hourcade
JD, FRd F, Gutiérrez-Adán A. Long-term effects of mouse Intracyto-
plasmic sperm injection with DNA-fragmented sperm on health and
behavior of adult Offspring1. Biol Reprod 2008; 78:761–772.
89. Aitken RJ, Krausz C. Oxidative stress, DNA damage and the Y chromo-
some. Reproduction 2001; 122:497–506.
90. Lee YC, Song IW, Pai YJ, Chen SD, Chen YT. Knock-in human FGFR3
achondroplasia mutation as a mouse model for human skeletal dysplasia.
Sci Rep 2017; 7:43220.
91. Heard E, Martienssen RA. Transgenerational epigenetic inheritance:
Myths and mechanisms. Cell 2014; 157:95–109.
92. Short AK, Yeshurun S, Powell R, Perreau VM, Fox A, Kim JH, Pang TY,
Hannan AJ. Exercise alters mouse sperm small noncoding RNAs and
induces a transgenerational modification of male offspring conditioned
fear and anxiety. Transl Psychiatry 2017; 7:e1114.
93. Gapp K, Jawaid A, Sarkies P, Bohacek J, Pelczar P, Prados J, Farinelli L,
Miska E, Mansuy IM. Implication of sperm RNAs in transgenerational
inheritance of the effects of early trauma in mice. Nat Neurosci 2014;
17:667–669.
94. Waterland RA, Jirtle RL. Transposable elements: Targets for early nutri-
tional effects on epigenetic gene regulation. Mol Cell Biol 2003; 23:
5293–5300.
95. Pennini ME, Perrinet S, Dautry-Varsat A, Subtil A. Histone methylation
by NUE, a novel nuclear effector of the intracellular pathogen chlamydia
trachomatis. PLoS Pathog 2010; 6:e1000995.
96. Kessler M, Hoffmann K, Fritsche K, Brinkmann V, Mollenkopf HJ,
Thieck O, Teixeira da Costa AR, Braicu EI, Sehouli J, Mangler M, Berger
H, Meyer TF. Chronic chlamydia infection in human organoids increases
stemness and promotes age-dependent CpG methylation. Nat Commun
2019; 10:1194.
97. Benyeogor I, Simoneaux T, Wu Y, Lundy S, George Z, Ryans K,
McKeithen D, Pais R, Ellerson D, Lorenz WW, Omosun T, Thompson W
et al. A unique insight into the MiRNA profile during genital chlamydial
infection. BMC Genomics 2019; 20:143.
98. Belva F, Bonduelle M, Roelants M, Michielsen D, Van Steirteghem A,
Verheyen G, Tournaye H. Semen quality of young adult ICSI offspring:
The first results. Hum Reprod 2016; 31:2811–2820.
99. Lu Y-h, Wang N, Jin F. Long-term follow-up of children conceived
through assisted reproductive technology. J Zhejiang Univ Sci B 2013;
14:359–371.
100. Ben Maamar M, Nilsson E, Sadler-Riggleman I, Beck D, McCarrey JR,
Skinner MK. Developmental origins of transgenerational sperm DNA









estern Sydney user on 23 June 2020
